Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

RNAC holding history

Cartesian Therapeutics, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RNAC overviewAll 13F holders of RNACFull Q4 2025 holdings

Shares (Q4 2025)
541,228
Value
$3.90M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of RNAC by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 2025541,228$3.90M<0.1%+20,506+3.9%AddedHolders
Q3 2025520,722$5.32M<0.1%+24,356+4.9%AddedHolders
Q2 2025496,366$5.16M<0.1%−7,171−1.4%ReducedHolders
Q1 2025503,537$6.64M<0.1%+74,057+17.2%AddedHolders
Q4 2024429,480$7.69M<0.1%+186,391+76.7%AddedHolders
Q3 2024243,089$3.92M<0.1%+6,432+2.7%AddedHolders
Q2 2024236,657$6.39M<0.1%−6,078,456−96.3%ReducedHolders
Q1 20246,315,113$4.10M<0.1%−928,919−12.8%ReducedHolders
Q4 20237,244,032$4.99M<0.1%+52,705+0.7%AddedHolders
Q3 20237,191,327$7.62M<0.1%+85,670+1.2%AddedHolders
Q2 20237,105,657$7.96M<0.1%+490,281+7.4%AddedHolders
Q1 20236,615,376$9.20M<0.1%+252,690+4.0%AddedHolders
Q4 20226,362,686$7.19M<0.1%+216,226+3.5%AddedHolders
Q3 20226,146,460$10.1M<0.1%+614,373+11.1%AddedHolders
Q2 20225,532,087$7.25M<0.1%−158,137−2.8%ReducedHolders
Q1 20225,690,224$7.00M<0.1%+521,993+10.1%AddedHolders
Q4 20215,168,231$16.8M<0.1%+104,234+2.1%AddedHolders
Q3 20215,063,997$21.1M<0.1%+29,196+0.6%AddedHolders
Q2 20215,034,801$21.0M<0.1%+90,642+1.8%AddedHolders
Q1 20214,944,159$22.4M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.